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Abstract
There is increasing evidence to suggest that the sinus microbiome plays a role in the patho-
genesis of chronic rhinosinusitis (CRS). However, the concentration of these microorgan-
isms within the sinuses is still unknown. We show that flow cytometry can be used to
enumerate bacteria and virus-like particles (VLPs) in sinus flush samples of CRS patients.
This was achieved through trialling 5 sample preparation techniques for flow cytometry. We
found high concentrations of bacteria and VLPs in these samples. Untreated samples pro-
duced the highest average bacterial and VLP counts with 3.3 ± 0.74 x 107 bacteria ml-1 and
2.4 ± 1.23 x 109 VLP ml-1 of sinus flush (n = 9). These counts were significantly higher than
most of the treated samples (p < 0.05). Results showed 103 and 104 times inter-patient vari-
ation for bacteria and VLP concentrations. This wide variation suggests that diagnosis and
treatment need to be personalised and that utilising flow cytometry is useful and efficient for
this. This study is the first to enumerate bacterial and VLP populations in the maxillary sinus
of CRS patients. The relevance of enumeration is that with increasing antimicrobial resis-
tance, antibiotics are becoming less effective at treating bacterial infections of the sinuses,
so alternative therapies are needed. Phage therapy has been proposed as one such alter-
native, but for dosing, the abundance of bacteria is required. Knowledge of whether phages
are normally present in the sinuses will assist in gauging the safety of applying phage ther-
apy to sinuses. Our finding, that large numbers of VLP are frequently present in sinuses,
indicates that phage therapy may represent a minimally disruptive intervention towards the
nasal microbiome. We propose that flow cytometry can be used as a tool to assess micro-
bial biomass dynamics in sinuses and other anatomical locations where infection can cause
disease.
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Introduction
Chronic rhinosinusitis (CRS) is a common disease amongst the human population, and there
is increasing evidence to show that microorganisms are involved in the inflammation of the
sinus mucosal layer leading to exacerbation of the disease [1–3]. It is well established that the
healthy sinus is not sterile, but is colonised by a diverse community of microorganisms [1, 2, 4,
5]. These microorganisms exist in the sinuses within exopolysaccharide biofilms, the presence
of which leads to difficulties in treating the disease [6–12]. As antibiotics are a common treat-
ment option for CRS patients, there is concern surrounding the growing antimicrobial resis-
tance [13, 14]. Bacteria within these biofilms are able to secrete a polysaccharide matrix that
acts as a protective barrier against host defences and antimicrobial agents [15]. This protective
barrier makes it difficult when it comes to treating CRS with antibiotics. An alternative treat-
ment is phage therapy which utilises specific bacteriophages (phage) that infect and kill patho-
genic bacteria [16]. Trials of bacteriophage cocktails consisting of multiple types of phage, on
sheep models of sinusitis have proven to be effective in eliminating S. aureus in biofilms and its
free floating form [17]. Through the use of these phage cocktails, the development of phage
resistant bacteria is reduced [18]. Knowledge of population abundance of bacteria and phage in
the sinuses is important for the development of appropriate phage concentrations for use in
this therapy [19].
Flow cytometry has been used as a method for enumerating heterotrophic bacteria and
virus-like particles (VLPs) in environmental samples for decades [20–22]. This non-culture
based technology is a quick, inexpensive way to rapidly enumerate a large number of cells and
particles to provide data without the enrichment bias culturing introduces [20]. This technique
yields highly reproducible counts and enumeration of VLPs at a concentration that would be
too low for transmission electron microscopy (TEM) [20]. Here, we investigate methods to
enumerate bacteria and VLPs within sinus flush fluid samples and present the first data, pro-
duced using flow cytometry, describing bacterial and VLP abundance within the maxillary
sinuses of CRS patients. We, therefore, aim to measure the variation in abundance of bacteria




Maxillary sinus flush fluid samples were obtained from nine patients diagnosed with CRS in
accordance to criteria defined by the Chronic Rhinosinusitis Task Force [23]. This study was
approved by The Queen Elizabeth Hospital Human Research Ethics Committee, reference
number: HREC/13/TQEHLMH/49. All nine patients involved in the study gave written con-
sent prior to their sinus surgery. All sinus flush fluid samples were collected by the senior
author (P.J.W) during the patient’s endoscopic sinus surgery. Due to the highly invasive nature
of the operating procedure, healthy controls were not ethically justifiable, nor are they relevant
to the question of how much abundance variation is there among infected patients.
Sample collection. Immediately after opening the maxillary sinus, approximately 5 ml of
sterile saline was used to flush the sinus and re-collected in sterile specimen containers. Volume
of flush fluid collected ranged from approximately 2 to 4 ml. Once samples were collected, they
were transported on ice ready for immediate fixation with glutaraldehyde (0.5% final concen-
tration) on ice in the dark, then snap freezing in liquid nitrogen and storage at -80°C until anal-
ysis [21].
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Sample Preparation
Five sample preparation techniques for flow cytometry were investigated. Fixed sinus flush
fluid samples were thawed before each treatment was applied.
Sputasol. Sputasol was made using 0.02 μm filtered MilliQ water according to the manu-
facturer’s instructions (Oxoid). Equal volumes of Sputasol and fixed sinus sample were mixed
together then incubated at 37°C for 15 minutes.
Methanol. Methanol, 0.2 μm filtered, was added to fixed sinus samples to a final concen-
tration of 20% [24]. Samples were incubated at 37°C for 15 minutes then sonicated for 30 sec-
onds in a SoniClean™ sonicating bath (Model 160TD, 60 W, 50/60Hz).
Potassium citrate. Potassium citrate tribasic solution (1M, Sigma) was added to the fixed
sample to a 1% final concentration [24]. The sample was then vortexed for 30 seconds [24].
Sodium pyrophosphate. Sodium pyrophosphate solution was added to 100 μl of fixed
sample to a final concentration of 10 mM [24]. Samples were vortexed for 1 minute and incu-
bated at room temperature for 15 minutes [24]. Samples were then sonicated for 30 seconds in
a SoniClean™ sonicating bath (Model 160TD, 60 W, 50/60Hz).
Untreated. Fixed samples were diluted in 0.2μm filtered TE buffer (10 mM Tris, 1 mM
EDTA, pH 7.4) without pre-treatment [21].
Flow Cytometric Analysis
Bacterial and VLP populations present in sinus flush fluid were identified and enumerated
using a BD ACCURI C6 flow cytometer (Becton Dickinson). Samples using each extraction
technique were run in triplicate for each patient. Samples were diluted (1:100) in 0.2 μm filtered
TE buffer, stained with the DNA-binding dye SYBR-I Green (1:20,000 final dilution; Molecular
Probes) then incubated at 80°C in the dark for 10 minutes [21]. For each preparation method
control samples were generated prior to each flow cytometry session. These samples were pre-
pared in the same manner as patient samples in 0.9% sterile saline, the same concentration
used to flush patient sinuses. These samples were used to eliminate background artefacts intro-
duced during sample preparation.
Samples were analysed using an Accuri C6 flow cytometer (Accuri C6) and BD ACCURI
CFlow software. All samples were run for 2 minutes at machine fluidics setting of fast, with the
threshold set to FL-1 (green fluorescence). As a control, 1 μm diameter fluorescent beads
(Molecular Probes) were used. Beads were added to each sample to a final concentration of 105
beads ml-1 [25]. The beads allow for flow cytometric parameters to be normalised according to
bead fluorescence and concentration, and to give an indication of viral and bacterial cell size
[25]. Phosphate-buffered saline (PBS) was used as sheath fluid for flow cytometry analysis. For
each sample, green fluorescence, side angle light scatter and forward angle light scatter were
recorded.
Data Analysis
Flow cytometry data was analysed using FlowJo software (Tree Star, Inc.). VLP and bacterial
populations were categorised based on variations in side scatter, a representation of cell size,
and SYBR Green fluorescence, an indication of nucleic acid content [20, 21, 26]. For some
patients, only one bacterial population was observed, whereas others showed multiple. There-
fore, one overall bacterial population was created to remain consistent across all patient
samples.
Rank abundance plots were generated for bacterial and VLP concentrations using all
method triplicates and their averages to distinguish between any patient groupings formed on
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abundance. Comparisons between bacterial and VLP abundances for each treatment method
were made using the statistical analysis program SPSS version 22 (IBM Corp. Released 2013.
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.) using the Wilcoxon
signed-rank test. Statistical significance between treatments was considered when p< 0.05.
Results
Flow Cytometric Analysis
Cytograms showed discrete bacterial and VLP populations present within the sinus fluid of
CRS patients (Fig 1). Some patients exhibited one distinct bacterial population, whereas others
patients exhibited up to four (Fig 1). Variations in bacterial and VLP abundance were observed
between patients regardless of the treatment method used on the samples. Mean bacterial and
VLP abundances for each treatment method are shown in Table 1.
Fig 1. Bacterial and VLP identification using side-scatter and green fluorescence.Representative
cytogram shows the VLP and bacterial populations in a patient’s untreated sinus wash.
doi:10.1371/journal.pone.0155003.g001
Table 1. Mean concentration of bacteria and VLP per ml of sinus flush fluid for each treatment method
tested. Error represents standard error of the mean.
Treatment Bacteria ml-1 (±SE) VLP ml-1 (±SE)
Untreated 3.3 x 107 (7.4 x 106) 2.4 x 109 (1.2 x 109)
Sodium pyrophosphate 2.9 x 107 (6.7 x 106) 2.0 x 109 (9.9 x 108)
Sputasol 2.2 x 107 (6.5 x 106) 1.8 x 109 (9.1 x 108)
Methanol 2.0 x 107 (4.3 x 106) 2.2 x 109 (9.9 x 108)
Potassium citrate 1.9 x 107 (4.6 x 106) 2.2 x 109 (1.1 x 109)
doi:10.1371/journal.pone.0155003.t001
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Bacterial Sample Preparation Method Optimisation
For patient samples, the mean bacterial abundance for untreated samples was the highest of all
treatments, with 3.3 ± 0.74 x 107 cells ml-1 (n = 27; Table 1; S1 Table). The lowest mean abun-
dance was for potassium citrate treated samples with 1.9 ± 0.46 x 107 cells ml-1 (n = 27; Table 1;
S1 Table). In testing the differences between treatments, the untreated and sodium pyrophos-
phate samples yielded significantly higher bacterial abundance than potassium citrate
(p< 0.001 and p< 0.001), methanol (p = 0.002 and p< 0.001) and Sputasol (p = 0.003 and
p< 0.001). There was no significant difference in bacterial abundance between sodium pyro-
phosphate treated and untreated samples (p = 0.39).
VLP Sample Preparation Method Optimisation
VLP mean abundance for the untreated method was the highest for all patient samples with
2.4 ± 1.2 x 109 cells ml-1 (n = 27; Table 1; S2 Table). Sputasol treated patient samples yielded
the lowest VLP abundances with 1.8 ± 0.91 x 109 cells ml-1 (n = 27; Table 1; S2 Table).
Untreated samples yielded significantly higher VLP abundances than potassium citrate
(p = 0.031), methanol (p = 0.010), and Sputasol (p = 0.019) treated samples. There was no sig-
nificant difference between VLP abundance for untreated samples and sodium pyrophosphate
treated samples (p = 0.08). Sodium pyrophosphate also did not yield significantly higher VLP
abundances than potassium citrate (p = 0.44) and methanol (p = 0.53) treated samples. There
was, however, a significant difference between VLP abundances for sodium pyrophosphate
and Sputasol (p = 0.008).
Bacterial Rank Abundance
Rank abundance was used to identify possible groupings among the patient’s bacterial abun-
dance. Breaks in the plot suggest 3 groupings of patients with bacterial abundances classified as
high, greater than 107 cells ml-1, medium, between 105 to 106 cells ml-1, and low, less than 105
cells ml-1 (Fig 2). The high bacterial group consisted of triplicates from 5 patients. The medium
bacterial group contained triplicates from 3 patients and the low bacterial abundance group
consisted of 1 patient. There was approximately one order of magnitude difference between
each of the 3 groups (Fig 2). The overall average bacterial rank abundance using all treatment
triplicates fit a logarithmic trend; however this was achieved by a series of step down power
laws for each bacterial group (Fig 3).
VLP Rank Abundance
A rank abundance plot for VLP abundance was generated using the method triplicates of
untreated, sodium pyrophosphate, potassium citrate, Sputasol and methanol samples (Fig 4).
VLP abundances show an even distribution across 5 orders of magnitude. Three patients had
values above 108 VLP ml-1. These are classified as high VLP, with the proviso that they are sep-
arated from each other by an order of magnitude (Fig 4). Three patients make up the medium
concentration group between 107 and 108 VLP ml-1. However, in this group the loss of VLPs in
the methanol and sodium pyrophosphate treatments makes the group appear fused with the
lowest group. The lowest group was classified as concentrations below 107 VLP ml-1. In this
group the methanol treatment showed considerable loss of VLPs and in one patient a complete
absence of VLPs (Fig 4). The overall average VLP rank abundance using all treatment tripli-
cates fit a steep power law (Fig 5).
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Lack of Correlation with Patient Symptoms
Prior to sinus surgery, each patient completed a questionnaire regarding basic clinical informa-
tion and provided a severity score from 0, being no problem, to 5, being a problem as bad as it
can be, for CRS symptoms for the past two weeks. Based on the rank abundance plots (Figs 2
and 3), possible trends in the patient groups were investigated. There were no trends observed
within the rank abundance patient groups for bacteria or VLPs.
Discussion
This is the first study to use flow cytometry to enumerate bacteria and VLPs within the maxil-
lary sinus of CRS patients. We present a number of snapshot enumerations, using flow cytome-
try, of the microbial composition of sinuses of CRS patients. We tested a number of sample
preparation techniques for bacterial and VLP enumeration that are used for environmental
samples, in particular, techniques used for disruption of coral mucus, for microscopy [24, 27].
Our results showed that the sinus, at least in patients requiring sinus surgery, is an active micro-
biological environment. We speculate that most VLPs detected are likely to be bacteriophages
Fig 2. Rank abundance for each patient’s bacterial abundance for each sample treatment method, with triplicates shown. Three
clear groups of patients with high, medium and low bacterial abundances are apparent. Differences in treatments used on the samples can
be seen not to influence steps of bacterial abundance for patients.
doi:10.1371/journal.pone.0155003.g002
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as they are the most commonly found in association with their hosts, bacteria, which we find to
be present in abundance in sinuses. The proposal that phages can be used to treat bacterial
infections of the sinus [17] can now be viewed in the light of this data showing that phages
appear to be present in sinuses in large numbers (Table 1).
Although the primary focus of this study was to enumerate the bacteria and VLPs in the
sinus fluid, there was concern surrounding the presence of small fragments of mucus or bio-
films within the samples prepared for flow cytometry. The mucus may have caused the bacteria
and VLPs to clump together resulting in an overestimation on particle size, shape and DNA
content. This is a similar concern in regards to analyzing bacteria and VLPs in coral mucus
using microscopy [24, 27]. As bacterial and VLP flow cytometry on human samples is a new
approach, various flow cytometry methods were investigated.
Common chemicals used in environmental sample preparation include potassium citrate,
sodium pyrophosphate and methanol. Sodium pyrophosphate and potassium citrate are com-
monly used in environmental microbiology for desorbing viral particles from soil and marine
sediment [28, 29]. Potassium citrate increases the electrostatic repulsion between viruses and
Fig 3. Average bacterial rank abundance using all treatment triplicates. Data points follow a logarithmic trend achieved by steps of power
laws for each observed group. High medium and low bacterial concentration groups fit the power law equations y = 2E+08x-0.84 (R2 = 0.84),
y = 5E+10x-3.57 (R2 = 0.98) and y = 6E+09x-3.49 (R2 = 1) respectively.
doi:10.1371/journal.pone.0155003.g003
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bacteria, and the mucus to which they are attached to by raising pH [24]. Sodium pyrophos-
phate weakens the hydrophilic links in mucus allowing for viruses and bacteria to be separated
[30]. Dithiothreitol (DTT) has been used on sinus samples to improve the yield of fungal cul-
tures and in studies involving quantification of inflammatory cells in nasal secretions [31–33].
Sputasol contains DTT and has been used to liquefy mucus in nasal lavage [34]. It does this by
breaking disulfide bonds within mucin, causing liquefaction, releasing trapped viruses and bac-
teria [35, 36]. Methanol has the ability to break up exopolymeric substances in mucus which
entrap bacteria and viruses [37].
Our results show that the untreated and sodium pyrophosphate treatment methods yielded
significantly higher bacterial abundances than all other methods tested (p< 0.05). For VLP
enumeration, no treatment (as in the untreated samples) was the optimal method. Although
there was no significant difference between untreated and sodium pyrophosphate treated sam-
ples (p< 0.05), sodium pyrophosphate did not yield significantly higher VLP abundances than
methanol and potassium citrate (p< 0.05). This result contrasts to previous microscopy stud-
ies which found potassium citrate better for viral enumeration in coral mucus [24]. Unlike
Fig 4. Rank abundance for each patient’s VLP abundance for each sample preparation method, with triplicates shown.Highest
abundances are rare while lower abundances are common. Differences in treatments used on the patient samples can be seen not to influence
the high range of VLP origination levels.
doi:10.1371/journal.pone.0155003.g004
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sample preparation for coral mucus for microscopy, flow cytometry includes an incubation
period after addition of SYBR Green. During this step viral capsids may partially and tempo-
rarily denature, facilitating a greater uptake of SYBR Green [20]. This may result in brighter
VLP fluorescence resulting in higher counts for all samples. It is also possible that the extra
processing steps involved with each treatment resulted in the loss of bacteria and VLPs. All
samples were diluted for flow cytometry in TE buffer which contained 1 mM of EDTA. EDTA
has been used to extract bacteria and viruses from photosynthetic microbial mats as it destroys
cation links within exopolymeric substances, releasing bound bacteria and viruses [38]. It also
permeabilises outer membranes, facilitating greater uptake of SYBR Green [39]. Additional
treatment to each sample could have an adverse effect, causing damage to viral capsid proteins
or to bacterial cell walls. Our data suggests that the least possible number of processing steps
and addition of chemicals is the optimal method for analyzing sinus flush samples.
Previous studies have shown that the human sinus is colonized with an array of microbes
[1, 2, 6–12, 40]. Flow cytometry enables categorization and enumeration of these microbes
based on size and DNA content [21, 26]. Some patient’s cytograms revealed numerous bacte-
rial sub-populations (Fig 1). These populations displayed increased green fluorescence, an indi-
cation of DNA content, and size. These different sub-populations may be reflecting different
Fig 5. Average VLP rank abundance using all treatment triplicates. Data points follow a power law.
doi:10.1371/journal.pone.0155003.g005
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bacterial replication stages or are indicative of different bacterial species with different sized
genomes. In the Sputasol treated patient samples, an unusual population was observed between
the bacterial and VLP regions. This population appears to be an artifact of the Sputasol as it
was also observed in the control samples (S1 Fig). Thus, there may be a component within Spu-
tasol which autofluorescences or binds to SYBR Green.
Large variations were observed between patients bacterial and VLP concentrations, which is
not uncommon with human microbial flora studies [41–45]. These findings suggest that the
maxillary sinus is either extremely dynamic or highly individualised. These differences in the
patient microbial concentrations could indicate the need for personalised dosages when treat-
ing CRS with antibiotics or with phage. The rank abundance plot for patient bacterial abun-
dance revealed 3 groupings of high, medium and low abundance (Fig 2). As the treatments
used on the samples were not seen to account for the differences in bacterial and VLP levels
(Figs 2 and 4), an average of all treatment values was used to clearly demonstrate the obvious
trends in bacterial concentration groups (Fig 3) and high episodic nature of the VLPs (Fig 5).
For the bacterial rank abundance, the three orders of magnitude range among the 9 patients
may reflect temporal variation or that the bacterial abundances are defined by processes or a
variable that was not measured. The skew of the distribution towards the lower concentrations
in the VLP rank abundance is consistent with the highly episodic nature of viral infections, par-
ticularly in bacteriophage where large burst sizes can quickly reduce the concentrations of par-
ticular bacterial species, leaving high bacteriophage concentrations at least temporarily [46].
From this, one might posit that time series sampling would show an eventual decline in VLP
concentration. While bacteriophage dynamics is one likely explanation for the observed distri-
bution, at this point we cannot discount that some patients have chronically high VLP concen-
trations. To investigate this and its clinical significance would require flow cytometric and
nucleic acid sequence analysis of time series samples from the identified patients. Due to the
invasive nature of sampling used in this study, healthy controls and a time series using the
same sampling method may not be a feasible option. Therefore there is the need to develop a
proxy for an alternative less invasive sampling strategy, such as nasal swabbing. While this is
beyond the scope of this paper, it is a potentially valuable future direction.
Knowledge of the abundance of microorganisms in CRS will further our understanding of
the disease as the presence of certain bacterial species does not always imply infection. The aim
of his research was to produce a snapshot enumeration of the sinus microbes of 9 patients
known to suffer from CRS, and to determine if they had similar abundances of bacteria and
VLPs. Within the group of 9 patients sampled, there was 3 orders of magnitude difference in
abundance for bacterial populations and almost 4 orders of magnitude difference for VLPs.
This suggests that not all CRS patients are infected at the same level of bacteria and VLPs.
Knowledge of the differences in bacterial abundances may facilitate the development of person-
alised treatment options.
This work indicates the potential for future studies in other microbial disease related health
conditions. We propose that flow cytometry has potential as a tool to monitor microbial
dynamics in patients and in future may assist in determining appropriate dosages required
when treating microbial related health conditions.
Supporting Information
S1 Fig. Representative cytogram showing the Sputasol artefact population observed
between the VLP and bacterial populations.
(TIF)
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S1 Table. Patients total bacterial abundances for each optimisation method. Replicates
(Rep) for each method are shown.
(PDF)
S2 Table. Patients total VLP abundances for each optimisation method. Replicates (Rep) for
each method are shown.
(PDF)
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